An ultrasensitive, rapid and portable method for screening oseltamivir-resistant virus based on CRISPR/Cas12a combined with immunochromatographic strips: Screening oseltamivir-resistant virus with CRISPR/Cas12a

Influenza is a significant public health challenge because of the emergence of antigenically shifted or highly virulent strains. The neuraminidase inhibitor oseltamivir is used as an antiviral drug in clinical treatment. However, its therapeutic effects can be greatly compromised by the emergence of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hao, Yang, Fayu, Yang, Man, Liu, Jing, Wang, Mi, Fei, Chenzhong, Zhang, Lifang, Xue, Feiqun, Zhu, Chuangang, Liu, Yingchun, Gu, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828330/
https://www.ncbi.nlm.nih.gov/pubmed/36604145
http://dx.doi.org/10.3724/abbs.2022163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828330/
https://www.ncbi.nlm.nih.gov/pubmed/36604145
http://dx.doi.org/10.3724/abbs.2022163

Ejemplares similares